Northpointe Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Northpointe Capital’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-175,010	Closed	-$1.65M	–	217
2015 Q2	$1.65M	Sell	175,010 -85,975	-33%	-$796K	0.19%	168
2015 Q1	$2.31M	Buy	260,985 +150,420	+136%	+$1.52M	0.25%	136
2014 Q4	$1.11M	Buy	110,565 +34,070	+45%	+$292K	0.13%	191
2014 Q3	$513K	Buy	+76,495	New	+$536K	0.05%	231

Other funds holding BEAT

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAD

Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Northpointe Capital's BEAT Position: Q3 2015 in Review

Northpointe Capital sold out of BioTelemetry, Inc. (BEAT) in Q3 2015, closing a stake of 175,010 shares — an estimated $1.65M sold.

Northpointe Capital first reported a position in BEAT in Q3 2014 and held it in 4 quarters. The position peaked at $2.31M in Q1 2015. 119 funds tracked by Wall St. Rank hold BEAT as of Q3 2015.

Northpointe Capital reported no remaining BioTelemetry, Inc. position as of Q3 2015 after selling out during the quarter.
Northpointe Capital sold 175,010 BioTelemetry, Inc. shares in Q3 2015, an estimated $1.65M.
Northpointe Capital first reported a position in BioTelemetry, Inc. in Q3 2014 and held it in 4 quarters.
Northpointe Capital's BioTelemetry, Inc. position peaked at $2.31M in Q1 2015.
119 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2015.

Based on Northpointe Capital's 13F filing for Q3 2015, filed 27 Oct 2015.